CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Eximias Pharmaceutical

For profit
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Sep 1, 2000

Last known activity

Sep 1, 2000

Acquired by YM Biosciences → Gilead Sciences on Apr 1, 2006

Timeline

1990s

  1. Jun 1, 1997

    Eximias Pharmaceutical— Founded

2000s

  1. Apr 1, 2006

    YM Biosciences— Acquired By

2010s

  1. Feb 11, 2013

    Gilead Sciences— Now

Drugs by trial phase (2 distinct, 1 trials)

Phase 3 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (2)

Details

Founded
Berwyn, PA, US Jun 1, 1997
Last known activity
Sep 1, 2000